Top 10 Antibody Drug Approvals from FDA 2023

Antibodies are an essential part of our immune system, and over the years, scientists have developed a range of antibody-based drugs that are used to treat various diseases. In recent years, many antibody drugs have received approval from the US Food and Drug Administration (FDA) for their safety and effectiveness. Here are the top 10 antibody drugs approved by the FDA: 

1. Humira (adalimumab): This antibody drug is used to treat a range of autoimmune diseases, including rheumatoid arthritis and psoriasis. 

2. Rituxan (rituximab): This antibody drug is used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis. 

3. Avastin (bevacizumab): This antibody drug is used to treat certain types of cancer, including colon, lung, and brain cancer. 

4. Herceptin (trastuzumab): This antibody drug is used to treat HER2-positive breast cancer. 

5. Remicade (infliximab): This antibody drug is used to treat autoimmune diseases, including Crohn's disease and rheumatoid arthritis. 

6. Keytruda (pembrolizumab): This antibody drug is used to treat various types of cancer, including melanoma, lung cancer, and head and neck cancer. 

7. Opdivo (nivolumab): This antibody drug is used to treat various types of cancer, including melanoma, lung cancer, and kidney cancer. 

8. Erbitux (cetuximab): This antibody drug is used to treat colon cancer and head and neck cancer. 

9. Prolia (denosumab): This antibody drug is used to treat osteoporosis. 

10. Xolair (omalizumab): This antibody drug is used to treat asthma and allergic rhinitis. 

At Biointron, we offer high-quality recombinant antibody production services that can help researchers and biotech companies develop antibody-based drugs for various diseases. Our team of experts can provide customized solutions that meet your specific research needs. Contact us to learn more about our services and how we can help accelerate your research and drug development projects.